GNS561 ALONE OR IN COMBINATION WITH CISPLATIN OR GEMCITABINE FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA

Meeting Abstract: 352

Sonia Brun (1) , Christelle Ansaldi , Firas Bassissi , Cindy Serdjebi (2) , Marie Novello , Jennifer Tracz , François Autelitano , Marie Guillemot , Philippe Fabre , Rachid, Madani , Jérôme Courcambeck , Eric Raymond , Philippe Halfon (3, 4)

1 IRIM - Institut de Recherche en Infectiologie de Montpellier
2 CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie
3 MEPHI - Microbes évolution phylogénie et infections
4 Hôpital Européen [Fondation Ambroise Paré - Marseille]

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Sonia Brun, Christelle Ansaldi, Firas Bassissi, Cindy Serdjebi, Marie Novello, et al.. GNS561 ALONE OR IN COMBINATION WITH CISPLATIN OR GEMCITABINE FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Nov 2019, Boston,MA, United States. pp.224A-225A. ⟨hal-02466474⟩